200 related articles for article (PubMed ID: 34283663)
1. The Knockdown of
Wang L; Zhang Y; Yang J; Liu L; Yao B; Tian Z; He J
DNA Cell Biol; 2021 Sep; 40(9):1211-1221. PubMed ID: 34283663
[TBL] [Abstract][Full Text] [Related]
2. CRLF1-MYH9 Interaction Regulates Proliferation and Metastasis of Papillary Thyroid Carcinoma Through the ERK/ETV4 Axis.
Yu ST; Sun BH; Ge JN; Shi JL; Zhu MS; Wei ZG; Li TT; Zhang ZC; Chen WS; Lei ST
Front Endocrinol (Lausanne); 2020; 11():535. PubMed ID: 32982961
[TBL] [Abstract][Full Text] [Related]
3. Circular RNA hsa_circ_0001666 sponges miR‑330‑5p, miR‑193a‑5p and miR‑326, and promotes papillary thyroid carcinoma progression via upregulation of ETV4.
Qi Y; He J; Zhang Y; Wang L; Yu Y; Yao B; Tian Z
Oncol Rep; 2021 Apr; 45(4):. PubMed ID: 33760216
[TBL] [Abstract][Full Text] [Related]
4. Circular RNA circ_0008274 enhances the malignant progression of papillary thyroid carcinoma via modulating solute carrier family 7 member 11 by sponging miR-154-3p.
Ma J; Kan Z
Endocr J; 2021 May; 68(5):543-552. PubMed ID: 33473055
[TBL] [Abstract][Full Text] [Related]
5. Interaction of BRAF-induced ETS factors with mutant TERT promoter in papillary thyroid cancer.
Song YS; Yoo SK; Kim HH; Jung G; Oh AR; Cha JY; Kim SJ; Cho SW; Lee KE; Seo JS; Park YJ
Endocr Relat Cancer; 2019 Jun; 26(6):629-641. PubMed ID: 30999281
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of lncRNA SLC26A4-AS1 inhibits papillary thyroid carcinoma progression through recruiting ETS1 to promote ITPR1-mediated autophagy.
Peng D; Li W; Zhang B; Liu X
J Cell Mol Med; 2021 Sep; 25(17):8148-8158. PubMed ID: 34378314
[TBL] [Abstract][Full Text] [Related]
7. Silencing lncRNA SLC16A1-AS1 Induced Ferroptosis in Renal Cell Carcinoma Through miR-143-3p/SLC7A11 Signaling.
Li YZ; Zhu HC; Du Y; Zhao HC; Wang L
Technol Cancer Res Treat; 2022; 21():15330338221077803. PubMed ID: 35167383
[No Abstract] [Full Text] [Related]
8. Knockdown of circPUM1 impedes cell growth, metastasis and glycolysis of papillary thyroid cancer via enhancing MAPK1 expression by serving as the sponge of miR-21-5p.
Li Y; Qin J; He Z; Cui G; Zhang K; Wu B
Genes Genomics; 2021 Feb; 43(2):141-150. PubMed ID: 33481227
[TBL] [Abstract][Full Text] [Related]
9. Long noncoding RNA SNHG22 increases ZEB1 expression via competitive binding with microRNA-429 to promote the malignant development of papillary thyroid cancer.
Gao H; Sun X; Wang H; Zheng Y
Cell Cycle; 2020 May; 19(10):1186-1199. PubMed ID: 32306838
[TBL] [Abstract][Full Text] [Related]
10. FTO Prevents Thyroid Cancer Progression by SLC7A11 m6A Methylation in a Ferroptosis-Dependent Manner.
Ji FH; Fu XH; Li GQ; He Q; Qiu XG
Front Endocrinol (Lausanne); 2022; 13():857765. PubMed ID: 35721711
[TBL] [Abstract][Full Text] [Related]
11. ETV4 transcriptionally activates HES1 and promotes Stat3 phosphorylation to promote malignant behaviors of colon adenocarcinoma.
Yao D; Bao Z; Qian X; Yang Y; Mao Z
Cell Biol Int; 2021 Oct; 45(10):2129-2139. PubMed ID: 34270850
[TBL] [Abstract][Full Text] [Related]
12. BGL3 inhibits papillary thyroid carcinoma progression via regulating PTEN stability.
Zhao M; Yang F; Sang C; Yan C; Wang Z
J Endocrinol Invest; 2021 Oct; 44(10):2165-2174. PubMed ID: 33543443
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA‑766 inhibits papillary thyroid cancer progression by directly targeting insulin receptor substrate 2 and regulating the PI3K/Akt pathway.
Zhao J; Li Z; Chen Y; Zhang S; Guo L; Gao B; Jiang Y; Tian W; Hao S; Zhang X
Int J Oncol; 2019 Jan; 54(1):315-325. PubMed ID: 30387841
[TBL] [Abstract][Full Text] [Related]
14. Hsa_circ_0070440 promotes lung adenocarcinoma progression by SLC7A11-mediated-ferroptosis.
Zhao Y; Cui Q; Shen J; Shen W; Weng Y
Histol Histopathol; 2023 Dec; 38(12):1429-1441. PubMed ID: 36852950
[TBL] [Abstract][Full Text] [Related]
15. Long noncoding RNA cancer susceptibility candidate 2 suppresses papillary thyroid carcinoma growth by inactivating the AKT/ERK1/2 signaling pathway.
Huang F; Zhang Q; Chen W; Zhang H; Lu G; Chen J; Qiu C
J Cell Biochem; 2019 Jun; 120(6):10380-10390. PubMed ID: 30609134
[TBL] [Abstract][Full Text] [Related]
16. CircRNA circSTIL inhibits ferroptosis in colorectal cancer via miR-431/SLC7A11 axis.
Li Q; Li K; Guo Q; Yang T
Environ Toxicol; 2023 May; 38(5):981-989. PubMed ID: 36840697
[TBL] [Abstract][Full Text] [Related]
17. KPNA4 regulated by miR-548b-3p promotes the malignant phenotypes of papillary thyroid cancer.
Feng L; Wang R; Yang Y; Shen X; Shi Q; Lian M; Ma H; Fang J
Life Sci; 2021 Jan; 265():118743. PubMed ID: 33188837
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-31 inhibits papillary thyroid carcinoma cell biological progression by directly targeting SOX11 and regulating epithelial-to-mesenchymal transition, ERK and Akt signaling pathways.
Wang Y; Liu BG; Zhou CX
Eur Rev Med Pharmacol Sci; 2019 Jul; 23(13):5863-5873. PubMed ID: 31298337
[TBL] [Abstract][Full Text] [Related]
19. Long non-coding RNA ADAMTS9-AS1 attenuates ferroptosis by Targeting microRNA-587/solute carrier family 7 member 11 axis in epithelial ovarian cancer.
Cai L; Hu X; Ye L; Bai P; Jie Y; Shu K
Bioengineered; 2022 Apr; 13(4):8226-8239. PubMed ID: 35311457
[TBL] [Abstract][Full Text] [Related]
20. RBMS1 regulates lung cancer ferroptosis through translational control of SLC7A11.
Zhang W; Sun Y; Bai L; Zhi L; Yang Y; Zhao Q; Chen C; Qi Y; Gao W; He W; Wang L; Chen D; Fan S; Chen H; Piao HL; Qiao Q; Xu Z; Zhang J; Zhao J; Zhang S; Yin Y; Peng C; Li X; Liu Q; Liu H; Wang Y
J Clin Invest; 2021 Nov; 131(22):. PubMed ID: 34609966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
